TVTX insider files Form 144 to sell 60,000 shares

TVTX filed a Form 144 disclosing the intended sale of 60,000 shares of Common Stock on 04/01/2026.

Accepted by SEC EDGAR 04/01/2026 - 04:13 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

TVTX filed a Form 144 disclosing the intended sale of 60,000 shares of Common Stock on 04/01/2026. The filing lists the sale method as cash and records several prior dispositions in the past three months: 8,135; 51,865; 100,087; and 60,000 shares on specified dates.

Key Figures

Planned sale: 60,000 shares Sale method: Cash Prior sale: 8,135 shares +3 more

6 metrics

Planned sale 60,000 shares Securities To Be Sold on 04/01/2026

Sale method Cash Method disclosed for 60,000-share sale

Prior sale 8,135 shares Sold 01/23/2026 for $244,153.28

Prior sale 51,865 shares Sold 01/27/2026 for $1,560,982.50

Prior sale 100,087 shares Sold 02/03/2026 for $3,289,859.69

Prior sale 60,000 shares Sold 02/20/2026 for $1,805,765.69

Key Terms

Form 144, Option Granted, Securities To Be Sold

3 terms

Form 144 regulatory

"Filed disclosing the intended sale of 60,000 shares on 04/01/2026"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Option Granted financial

"Option Granted - 01/31/2020 listed alongside the 60,000-share sale"

Securities To Be Sold regulatory

"Common ... 60000 ... 04/01/2026 appears under Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did TVTX file in Form 144?

TVTX filed a Form 144 reporting an intended sale of 60,000 shares of Common Stock on 04/01/2026. The filing identifies the sale method as cash and includes prior sales during the preceding three months.

Who is listed as having sold shares recently in the TVTX filing?

The filing lists transactions by Eric M. Dube with sales of 8,135, 51,865, 100,087, and 60,000 shares on dates between 01/23/2026 and 02/20/2026, with proceeds stated for each disposition.

What sale proceeds are disclosed in the TVTX Form 144?

The Form 144 shows proceeds for recent dispositions: $244,153.28, $1,560,982.50, $3,289,859.69, and $1,805,765.69 associated with the listed share sales by the reporting person.

Does the TVTX Form 144 specify the sale method for the 60,000 shares?

Yes. The filing indicates the 60,000-share transaction on 04/01/2026 stems from an option granted and is to be sold for cash, with the grant date recorded as 01/31/2020 in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001763494
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Travere Therapeutics, Inc.
SEC File Number	001-36257
Address of Issuer	3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CALIFORNIA 92130
Phone	888-969-7879
Name of Person for Whose Account the Securities are To Be Sold	Dube Eric M
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	60000	1855654.74	92241550	04/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2026	Option Granted - 01/31/2020	Issuer			60000	04/01/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Eric M. Dube 3611 Valley Centre Drive, Suite 300 San Diego CA 92130	Common	01/23/2026	8135	244153.28
Eric M. Dube 3611 Valley Centre Drive, Suite 300 San Diego CA 92130	Common	01/27/2026	51865	1560982.50
Eric M. Dube 3611 Valley Centre Drive, Suite 300 San Diego CA 92130	Common	02/03/2026	100087	3289859.69
Eric M. Dube 3611 Valley Centre Drive, Suite 300 San Diego CA 92130	Common	02/20/2026	60000	1805765.69

144: Remarks and Signature

Remarks
Date of Notice	04/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/16/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Eric M. Dube
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)